TScan Therapeutics Price Chart
TScan Therapeutics Volume Chart
TScan Therapeutics Market Segments
Regular Trading Hours
+0.07(+6.03%)
| Open | $1.16 |
|---|---|
| Close | $1.23 |
| Low | $1.14 |
| Low Change | -0.02 (-1.97%) |
| High | $1.23 |
| High Change | +0.07 (+6.03%) |
| Range | $0.09 |
| Volume | 436.588K |
| Dollar Volume | $537.00K |
Premarket
-0.01(-0.85%)
| Open | $1.17 |
|---|---|
| Close | $1.16 |
| Low | $1.16 |
| Low Change | -0.01 (-0.85%) |
| High | $1.19 |
| High Change | +0.02 (+1.49%) |
| Range | $0.03 |
| Volume | 3.744K |
| Dollar Volume | $4.34K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $1.17 |
|---|---|
| Close | $1.17 |
| Low | $1.17 |
| Low Change | 0.00 (0.00%) |
| High | $1.17 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1.465K |
| Dollar Volume | $1.71K |
Regular Trading Hours Yesterday
+0.03(+2.61%)
| Open | $1.15 |
|---|---|
| Close | $1.18 |
| Low | $1.13 |
| Low Change | -0.02 (-1.64%) |
| High | $1.20 |
| High Change | +0.05 (+4.35%) |
| Range | $0.07 |
| Volume | 403.744K |
| Dollar Volume | $476.42K |
Premarket Yesterday
-0.03(-2.54%)
| Open | $1.18 |
|---|---|
| Close | $1.15 |
| Low | $1.15 |
| Low Change | -0.03 (-2.54%) |
| High | $1.18 |
| High Change | +0.00 (+0.00%) |
| Range | $0.03 |
| Volume | 6.521K |
| Dollar Volume | $7.50K |
TScan Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.23 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.25 |
| 20 Day Moving Average (SMA20) | $1.15 |
| 50 Day Moving Average (SMA50) | $1.10 |
| 100 Day Moving Average (SMA100) | $1.07 |
| 200 Day Moving Average (SMA200) | $1.39 |
TScan Therapeutics Statistics
| Average Volume (30 Days) | 1.09M |
|---|---|
| P/E Ratio (Current) | -.58 |
| EPS (Current) | -$2.16 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$139.73M |
| Cash Ratio | 8.15 |
| Current Ratio | 8.41 |
| Quick Ratio | 8.41 |
| Debt to Equity | 0.26 |
| Enterprise Value | -$44.14M |
| EV to EBITDA | 0.33 |
| EV to Sales | -4.28 |
| Price to Book | 0.62 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 7.33 |
| Return on Assets | -0.57% |
| Return on Equity | -1.05% |
TScan Therapeutics Stock Splits
There have been no stock splits for TScan Therapeutics (TCRX).
TScan Therapeutics Dividends
There have been no dividends for TScan Therapeutics (TCRX).